SEC Filings TLDR

HOLD Alapkezelo Zrt., a Hungarian investment fund management company, has reported a 6.52% ownership in MediWound Ltd. as of December 31, 2024. The filing, made under Rule 13d-1(c), indicates that HOLD Alapkezelo Zrt. beneficially owns 703,429 shares of MediWound Ltd.'s common stock. The shares are held solely by HOLD ...

Davidson Kempner Capital Management LP and related entities have filed a Schedule 13G with the SEC, reporting a 7% ownership stake in LivePerson Inc. The filing includes M.H. Davidson & Co., Davidson Kempner Arbitrage, Equities and Relative Value LP, and Davidson Kempner Capital Management LP, with Anthony A. Yoseloff ...

Bitmine Immersion Technologies, Inc. has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 13,698,630 shares of common stock in Eightco Holdings Inc., representing 7.54% of the outstanding shares. The shares were acquired pursuant to a Securities Purchase Agreement dated September 8, 2025. The f...

This Schedule 13G filing discloses the beneficial ownership of shares of Bionano Genomics, Inc. by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. As of September 19, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 508,415 shares of Common Stock, representing a...

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing a 7.54% ownership stake in BioCardia, Inc. The filing indicates that Lincoln Alternative Strategies LLC beneficially owns 800,000 shares of BioCardia's common stock, with sole voting and dispositive power over these shares. The filing ...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G with the SEC regarding their beneficial ownership of Beta Bionics, Inc. The filing indicates that these entities collectively own 5.3% of the company's common stock, par value $0.0001 per share. The share...

BITMINE IMMERSION TECHNOLOGIES, INC. has filed a Schedule 13G with the SEC, disclosing its beneficial ownership of 13,698,630 shares of Common Stock in EIGHTCO HOLDINGS INC. This represents approximately 7.54% of the outstanding shares. The shares were acquired pursuant to a Securities Purchase Agreement dated Septembe...

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have jointly filed a Schedule 13G with the SEC, reporting a 5.80% ownership in BioCryst Pharmaceuticals, Inc. The filing indicates that these entities and individuals collectively own 12,169,000 shares of the company'...

John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust and in his individual capacity, filed a Schedule 13G with the SEC, disclosing beneficial ownership of 1,774,900 shares of Telomir Pharmaceuticals, Inc. common stock, representing 5.50% of the total shares. The filing indicates that the shares were not ...

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a Schedule 13G with the SEC, disclosing beneficial ownership of 6.0% of the Class A Common Stock of Strive, Inc. The filing, dated September 17, 2025, indicates that the shares are held by entities subject to voting control a...

Generate Strategic Credit Master Fund I-B, L.P., along with its related entities Generate Strategic Credit Fund GP, L.P., GCP Holdings I, LLC, and Generate Capital, PBC, have jointly filed a Schedule 13G to report their beneficial ownership of 3,345,829 shares of common stock in Soluna Holdings, Inc. This represents 9....

Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 224,050 ordinary shares of Silexion Therapeutics Corp, representing 9.9% of the company's outstanding shares. The filing includes details of the ownership structure, wi...

Alumni Capital LP, along with Alumni Capital GP LLC and Ashkan Mapar, filed a Schedule 13G for NextTrip, Inc. The filing indicates that the Reporting Persons may acquire up to 9.99% of the common stock of NextTrip, Inc. under a Securities Purchase Agreement dated September 19, 2024. The agreement allows the Fund to pur...

Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong have jointly filed a Schedule 13G with the SEC regarding their holdings in Maywood Acquisition Corp. As of September 12, 2025, Linden Advisors LP and Siu Min Wong each beneficially own approximately 6.7% of the Class A ordinary shares, while Linde...

Graphite India Limited, based in Kolkata, India, has reported ownership of 1,760,023 shares of common stock in GrafTech International Ltd, representing 6.8% of the total outstanding shares. The filing, submitted under Rule 13d-1(c), indicates that these shares are held solely by Graphite India Limited, with no shared v...

Orca Capital AG, a German entity, has filed a Schedule 13G with the SEC, disclosing its ownership of 4,809,500 shares of Co-Diagnostics, Inc.'s common stock, representing 9.9% of the total outstanding shares. The filing indicates that Orca Capital AG has sole voting and dispositive power over these shares. The shares w...

Pontifax VI G.P. L.P., Pontifax Management 4 G.P. (2015) Ltd., Ran Nussbaum, and Tomer Kariv have filed a Schedule 13G with the SEC, reporting beneficial ownership of 5,206,380 shares of common stock in Climb Bio, Inc., representing 7.7% of the total shares outstanding. The filing indicates that the shares are held by ...

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Bionano Genomics, Inc. The filing indicates that Iroquois Capital Management LLC owns 3.8% of the company's common stock, Richard Abbe owns 5.4%, and Kimberly Page ...

This Schedule 13G filing, submitted on September 17, 2025, reports the beneficial ownership of ordinary shares in Silexion Therapeutics Corp by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. The filing indicates that each of the reporting persons may be deemed to beneficially own 244,771 ordinary sha...

The Schedule 13G filing reports the beneficial ownership of Common Stock, $0.001 par value per share, of Semler Scientific, Inc. by several entities collectively referred to as Reporting Persons. These entities include Capital Ventures International, Susquehanna Advisors Group, Inc., G1 Execution Services, LLC, SIG Bro...

Portolan Capital Management, LLC and George McCabe have filed a Schedule 13G indicating their ownership in DOMO, INC. Portolan Capital Management, LLC, a registered investment adviser, directly owns shares in its capacity as investment manager for various clients. George McCabe, the Manager of Portolan Capital Manageme...

Vivo Opportunity Fund Holdings, L.P. and its affiliates, including Vivo Opportunity, LLC, Vivo Opportunity Cayman Fund, L.P., and Vivo Opportunity Cayman, LLC, have filed a Schedule 13G to report their beneficial ownership in Camp4 Therapeutics Corp. Vivo Opportunity Fund Holdings, L.P. beneficially owns 3,561,793 shar...

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, reporting a 5.42% ownership stake in Bionano Genomics, Inc. The filing indicates that Lincoln Alternative Strategies LLC beneficially owns 525,000 shares of Bionano Genomics' common stock. The shares are held solely by Lincoln Alternative Strateg...

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 9.1% of the common stock of Aptevo Therapeutics Inc. The filing, dated September 16, 2025, indicates that Point72 Asset Management maintains invest...

Calm Waters Partnership and Richard S. Strong have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Asure Software Inc. Calm Waters Partnership, a Wisconsin general partnership, and Richard S. Strong, a United States citizen, jointly filed this statement. Calm Waters Partnership hol...